Page 5 - Bdtx News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Bdtx. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Bdtx Today - Breaking & Trending Today

Black Diamond Therapeutics, Inc. (NASDAQ:BDTX) Expected to Post Q1 2022 Earnings of ($0.77) Per Share

Black Diamond Therapeutics, Inc. (NASDAQ:BDTX – Get Rating) – Equities researchers at Wedbush issued their Q1 2022 EPS estimates for shares of Black Diamond Therapeutics in a research report issued on Tuesday, March 29th. Wedbush analyst R. Driscoll anticipates that the company will post earnings per share of ($0.77) for the quarter. Wedbush currently has […] ....

United States , Stifel Nicolaus , Morgan Stanley , Diamond Therapeutics Inc , Zacks Investment Research , Blackrock Inc , Parametric Portfolio Associates , Black Diamond Therapeutics , Get Rating , Investment Research , Diamond Therapeutics , State Teachers Retirement System , Portfolio Associates , Retirement Systems , Nasdaq Bdtx , Earnings Estimates ,

Wedbush Downgrades Black Diamond Therapeutics (NASDAQ:BDTX) to Neutral

Black Diamond Therapeutics (NASDAQ:BDTX – Get Rating) was downgraded by equities researchers at Wedbush from an “outperform” rating to a “neutral” rating in a report issued on Tuesday, Briefing.com reports. A number of other analysts also recently weighed in on the stock. Stifel Nicolaus reduced their target price on shares of Black Diamond Therapeutics from […] ....

Stifel Nicolaus , Morgan Stanley , Geode Capital Management , Diamond Therapeutics Inc , Zacks Investment Research , Renaissance Technologies , Blackrock Inc , Black Diamond Therapeutics , Get Rating , Investment Research , Diamond Therapeutics , Capital Management , State Street Corp , Street Corp , Nasdaq Bdtx ,

HC Wainwright Downgrades Black Diamond Therapeutics (NASDAQ:BDTX) to Neutral

Black Diamond Therapeutics (NASDAQ:BDTX – Get Rating) was downgraded by HC Wainwright from a “buy” rating to a “neutral” rating in a research note issued on Tuesday, MarketBeat.com reports. Separately, Stifel Nicolaus lowered their price target on shares of Black Diamond Therapeutics from $10.00 to $4.00 and set a “hold” rating for the company in […] ....

United States , United Kingdom , Stifel Nicolaus , Diamond Therapeutics Company Profile Get Rating , Diamond Therapeutics Inc , Cambridge Investment Research Advisors Inc , Dynamic Technology Lab Private Ltd , Invesco Ltd , Walleye Trading , Black Diamond Therapeutics , Get Rating , Diamond Therapeutics , Technology Lab Private Ltd , Retirement Systems , Cambridge Investment Research Advisors , Diamond Therapeutics Company Profile , Nasdaq Bdtx , Hc Wainwright ,

Black Diamond Therapeutics (NASDAQ:BDTX) Releases Earnings Results, Beats Expectations By $0.29 EPS

Black Diamond Therapeutics (NASDAQ:BDTX – Get Rating) posted its earnings results on Thursday. The company reported ($0.71) earnings per share for the quarter, topping the Zacks’ consensus estimate of ($1.00) by $0.29, MarketWatch Earnings reports. Shares of NASDAQ BDTX traded up $0.04 during mid-day trading on Friday, reaching $3.06. The company had a trading volume […] ....

Stifel Nicolaus , Diamond Therapeutics Inc , Cubist Systematic Strategies , Virtu Financial , Invesco Ltd , Walleye Trading , Black Diamond Therapeutics , Get Rating , Marketwatch Earnings , Diamond Therapeutics , Systematic Strategies , Nasdaq Bdtx ,

Geode Capital Management LLC Reduces Stake in Black Diamond Therapeutics, Inc. (NASDAQ:BDTX)

Geode Capital Management LLC lowered its stake in Black Diamond Therapeutics, Inc. (NASDAQ:BDTX – Get Rating) by 2.7% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 349,980 shares of the company’s stock after selling 9,622 shares during the […] ....

United States , Morgan Stanley , Geode Capital Management , Blackrock Inc , Parametric Portfolio Associates , Exchange Commission , Diamond Therapeutics Inc , Healthcare Of Ontario Pension Plan Trust Fund , Black Diamond Therapeutics , Get Rating , Capital Management , Ontario Pension Plan Trust Fund , Retirement Systems , Portfolio Associates , Diamond Therapeutics , Visit Holdingschannel , Nasdaq Bdtx , Sec Filings , Hedge Fund Holdings , Institutional Investor Holdings ,